Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies
Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs
Cheryl Pegus has left Walmart Health and will join JP Morgan Chase & Co.’s Morgan Health venture as managing director, with aims to improve employer-sponsored healthcare
Morgan Health, the JPMorgan Chase & Co. business unit focused on improving the quality, equity and affordability of employer-sponsored health care
A growing number of organizations that offer more transparent pharmacy benefit management services are entering the market.
To grow its services Walmart Health is focused on the needs of the patient and customer by creating partnerships, most recently with Transcarent, a new and different health and care experience company putting people back in charge of their health and care experiences
JPMorgan Chase unveiled its new healthcare company, dubbed Morgan Health, which its top executive told Becker’s Hospital Review can be viewed as a continuation of Haven, an ambitious healthcare venture that recently disbanded.
A group that represents some of the largest employers in New York City issued a report urging the city to develop its own group purchasing organization for hospital supplies as a strategy to improve the city’s overall public health system. The report comes from the Partnership for New York City and Deloitte Consulting, The group […]